Floatz logo

Bcma Car-T Cells

Neoplasm, Plasma Cell

Chongqing Precision Biotech Co., LtdCell therapyPhase 1/2Active
CCC
48/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
95/ 100

Competitive context

20 Active assets in the Neoplasm, Plasma Cell cohort.

Asset / SponsorPhaseRating
DEXAMETHASONE
Hellenic Society of Hematology
Phase 3BBB
cc-5013
Hellenic Society of Hematology
Phase 3BBB
Cyclophosphamide
Affiliated Hospital to Academy of Military Medical Sciences
Phase 3BB
Fludarabine
Affiliated Hospital to Academy of Military Medical Sciences
Phase 3BB
Fludarabine
Affiliated Hospital to Academy of Military Medical Sciences
Phase 3BB

View all 50 →

Same molecule, other indications

Bcma Car-T Cells is also rated in:

plasma cell myelomaDormant
B
Indicative ·
58 / 100
View asset →
Relapsed/RefractoryDormant
CCC
Indicative ·
53 / 100
View asset →
neoplasmDormant
CCC
Indicative ·
53 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →